OAB treatment approved by the NHS
Designed to free up clinic time, and empower patients to manage treatment at home.
Managing Overactive Bladder (OAB) can be complex. Medications are often ineffective or poorly tolerated. Bladder interventions such as Botox or Percutaneous Posterior Tibial Nerve Stimulation (P-PTNS) require specialist input, with long waiting times to be seen.
We will cover how Tensi+ works, the latest safety and efficacy data from recent multicentre studies, and highlight Tensi+ can deliver meaningful benefits for both patients and the NHS.
Free us clinic time
Fewer weekly PTNS appointments gives you the time to focus on complex patients
Support the NHS
Alignment with NHS priorities of efficiency, sustainability, and patient-centred care
Simple
Easy for patients to use independently and manage their treatment at home
Effective
Validated in published multicentre clinical studies, showing 67% efficacy with high levels of patient satisfaction1
Clinical evidence and endorsements
Tensi+ is endorsed by leading urologists, with recent multicentre studies demonstrating its safety and effectiveness in helping manage overactive bladder symptoms.
67% patient efficacy after 3 months1
88% patient satisfaction, with high usability and tolerability1
Comparable outcomes to P-PTNS and Botox, without the need for repeated clinical appointments
Clinical Case Study
Breaking Free From Overactive Bladder: Real-life experience of five patients who successfully used Tensi+ to manage OAB symptoms.
European Urology Focus
New Tensi+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study.
The French Journal of Urology
Efficacy and Safety of the Tensi+ Device For Posterior Tibial Nerve Stimulation: A Multicenter, Retrospective Study.
The Canadian Journal of Urology
How I Do It: Transcutaneous Tibial Nerve Stimulation Tensi+ System.
Benefits for the NHS
Clear cost savings versus pharmacological and invasive interventions
Aligns with Getting It Right First Time (GIRFT) and MedTech initiatives
Supports Value-Based Procurement by reducing pathway costs, not just product cost
Contributes to NHS Net Zero targets by reducing hospital appointments
Minimises follow-up burden and frees up clinical time with patient self-management
Benefits for your patients
Many users see significant improvement after 12 weeks*
Can be used in the comfort and convenience of your patient’s home
Provides relief from symptoms of urgency, frequency and nocturia
A natural, non-invasive way to regain control
*Success rate of 67% after 3 months usage. 88% of patients rated their experience with the Tensi+ device as positive – New TENSI+ Device for Transcutaneus Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study, European Urology Focus (2024) J.-N. Cornu, L. Donon, C. Thullier et al.
How Tensi+ Works
Practical use
Tensi+ is a CE-marked, MHRA-registered medical device designed specifically for the treatment of OAB using Transcutaneous Posterior Tibial Nerve Stimulation (T-PTNS).
It has built-in electrodes to optimise tibial nerve stimulation, which are positioned just behind and below the ankle bone (medial malleolus) and secured in place with a strap. The device sends gentle electrical pulses through the skin to stimulate the posterior tibial nerve.
Is Tensi+ suitable for my patient? +–
Tensi+ is suitable for adults (18+). However, Tensi+ should not be used if your patient:
- Has a pacemaker, defibrillator, or any other electronic implant (risk of electric shock, malfunction, burns, or interference)
- Has a metal implant near the area of stimulation
- Has ankle joint issues, swollen ankles, a skin condition, or damaged skin at the electrode site
- Is pregnant
- Has a cognitive impairment
Jenny's experience with Tensi+
“Waking up less meant I finally had more energy.” After introducing Tensi+ alongside other lifestyle changes, Jenny began to notice real improvements in her symptoms and sleep.
View the video transcript +–
I used Tensi+ for 20 minutes a day for 12 weeks as instructed and I couldn’t believe the difference it made in terms of how often I was going to the loo during the day. The urgency was definitely reduced and I just found that I wasn’t constantly running to the loo I’m now only waking up twice a night and you know waking up less means that I get more sleep and therefore I’ve got much more energy.
I finally thought I had found something that would give me consistent relief to my overactive bladder symptoms. So I incorporated Tensi into my routine and alongside a holistic changes such as pelvic floor exercises mindfulness and and also thinking carefully about what I eat and drink.
How to order Tensi?
Order with SecuriCare
Patients who have been prescribed with Tensi+ can be referred to our sister company, SecuriCare. The SecuriCare service includes:
- Delivery of prescribed Tensi+ products directly to the patient’s home
- Ongoing supply of consumables as prescribed
- Access to the SecuriCare check-in support service
Product warranty support where required - Dedicated customer service support for ordering and product-related queries
Purchase through NHS Supply Chain
- Your procurement team emails NHS Supply Chain stating their intention to buy Tensi+ and the Tensi+ gel via DPS
- NHS Supply Chain provides a Statement of Requirements (SoR) form
- Procurement completes and returns the SoR. NHS Supply Chain will obtain a supplier quote from CliniMed for the number of units they require and issue a Purchase Order (PO)
- Tensi+ is delivered directly to your Trust
- Your hospital is invoiced by NHS Supply Chain, and payment is processed through the usual internal process
If none of these options work for your patients, they can order Tensi+ directly from CliniMed.
Products and order codes
Tensi+ device
Order code: PF0001
Tensi+ conductive gel (100ml)
Order code: PF0106
Replacement electrodes (2 pairs)
Order code: PF0105
References
- J.-N. Cornu, L. Donon, C. Thullier et al., New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study, Eur Urol Focus (2024), https://doi.org/10.1016/j.euf.2024.05.013
Have a question about Tensi+?
If you’d like to learn more about Tensi+ or have any questions, simply complete the form.
A member of our team will be in touch with you as soon as possible.